| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 118,947 | 148,989 | 186,347 | 126,957 | | Cost of Revenue | 95,649 | 103,950 | 127,787 | 83,042 | | | Gross Profit | 23,298 | 45,039 | 58,560 | 43,915 | | | Operating Expenses | | Research Development | 23,222 | 24,634 | 25,234 | 21,664 | | Selling General and Administrative | 16,808 | 17,426 | 21,148 | 18,758 | | Non Recurring | 4 | 33,875 | (101) | 1,416 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,736) | (30,896) | 12,279 | 2,077 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 644 | (2,004) | 758 | 1,532 | | Earnings Before Interest And Taxes | (16,092) | (32,900) | 13,037 | 3,609 | | Interest Expense | 318 | 400 | 134 | 10 | | Income Before Tax | (16,410) | (33,300) | 12,903 | 3,599 | | Income Tax Expense | (766) | 1,000 | 1,060 | 235 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,644) | (34,300) | 11,843 | 3,364 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (15,644) | (34,300) | 11,843 | 3,364 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,644) | ($34,300) | $11,843 | $3,364 |
|
1.91% Nasdaq 
Income Statement
